Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-09

Clinical Trial Update: Precision Medicine for Neurocutaneous Syndromes in Western China

View source ↗

Summary

A completed clinical trial from West China Hospital exploring precision medicine approaches for neurocutaneous syndromes, including NF1, TSC, Sturge-Weber syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: West China Hospital | Conditions: Neurocutaneous Syndromes, Neurofibromatosis Type 1 (NF1) | Status: COMPLETED